JP2006524342A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524342A5
JP2006524342A5 JP2006513114A JP2006513114A JP2006524342A5 JP 2006524342 A5 JP2006524342 A5 JP 2006524342A5 JP 2006513114 A JP2006513114 A JP 2006513114A JP 2006513114 A JP2006513114 A JP 2006513114A JP 2006524342 A5 JP2006524342 A5 JP 2006524342A5
Authority
JP
Japan
Prior art keywords
individual
complement
bound
platelets obtained
lupus erythematosus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006513114A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550051B2 (ja
JP2006524342A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011982 external-priority patent/WO2004093647A2/en
Publication of JP2006524342A publication Critical patent/JP2006524342A/ja
Publication of JP2006524342A5 publication Critical patent/JP2006524342A5/ja
Application granted granted Critical
Publication of JP4550051B2 publication Critical patent/JP4550051B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006513114A 2003-04-16 2004-04-16 全身性エリテマトーデスの同定およびモニタリング Expired - Lifetime JP4550051B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46344703P 2003-04-16 2003-04-16
PCT/US2004/011982 WO2004093647A2 (en) 2003-04-16 2004-04-16 Identification and monitoring of systematic lupus erythematosus

Publications (3)

Publication Number Publication Date
JP2006524342A JP2006524342A (ja) 2006-10-26
JP2006524342A5 true JP2006524342A5 (cg-RX-API-DMAC7.html) 2007-06-07
JP4550051B2 JP4550051B2 (ja) 2010-09-22

Family

ID=33310779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006513114A Expired - Lifetime JP4550051B2 (ja) 2003-04-16 2004-04-16 全身性エリテマトーデスの同定およびモニタリング

Country Status (7)

Country Link
US (3) US7588905B2 (cg-RX-API-DMAC7.html)
EP (1) EP1618379B1 (cg-RX-API-DMAC7.html)
JP (1) JP4550051B2 (cg-RX-API-DMAC7.html)
AT (1) ATE552501T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004232007B2 (cg-RX-API-DMAC7.html)
CA (1) CA2522261A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004093647A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060015646A (ko) 2003-06-13 2006-02-17 유니버시티 오브 피츠버그 면역, 혈액 및 염증성 질환의 모니터링 방법
US20080131914A1 (en) * 2005-09-14 2008-06-05 Ahearn Joseph M Assessing risk of cerebrovascular thrombosis by measuring c4d
US8062852B2 (en) 2007-10-01 2011-11-22 The Children's Hospital And Regional Medical Center Detection and treatment of autoimmune disorders
WO2010045611A2 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases
JP5625155B2 (ja) * 2010-07-30 2014-11-19 国立大学法人 東京大学 ホスファチジルセリン特異的ホスホリパーゼa1測定による全身性エリテマトーデスの検査方法および検査薬
EP2673644B1 (en) 2011-02-11 2016-02-10 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
US9863946B2 (en) 2013-02-08 2018-01-09 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
EP2954071B1 (en) 2013-02-08 2020-08-12 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
US11531033B2 (en) 2013-03-15 2022-12-20 Exagen Inc. Methods for treating and diagnosing systemic lupus erythematosus
US10105413B2 (en) 2013-06-13 2018-10-23 Medical Research & Development Fund for Health Services Bnai Zion Medical Center Semaphorin 3A for treatment of systemic lupus erythematosus
JP6674543B2 (ja) 2015-07-31 2020-04-01 アレゲーニー・シンガー リサーチ インスティチュート 抗体に基づく薬物のコンパニオン診断としての細胞結合補体活性化産物アッセイ
WO2017205532A1 (en) 2016-05-24 2017-11-30 Allegheny-Singer Research Institute Methods and systems using c4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU686577B2 (en) 1992-10-30 1998-02-12 Innogenetics, Inc. Measurement of total molecule in a sample and methods based thereon
EP1066368A4 (en) * 1998-03-02 2002-08-21 Compucyte Corp SELECTIVE CELL ANALYSIS
JP4570872B2 (ja) * 2001-09-10 2010-10-27 ユニヴァーシティ オブ ピッツバーグ 全身性紅斑性狼瘡および強皮症の診断およびモニタリング方法
KR20060015646A (ko) * 2003-06-13 2006-02-17 유니버시티 오브 피츠버그 면역, 혈액 및 염증성 질환의 모니터링 방법
EP1756571B8 (en) * 2004-04-09 2010-10-13 University of Pittsburgh - Of the Commonwealth System of Higher Education Real time method of detecting acute inflammatory conditions
ES2353311T3 (es) * 2004-05-11 2011-03-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnóstico de enfermedades o afecciones inflamatorias para la medición de componentes del complemento sobre la superficie de glóbulos blancos.
US7679298B2 (en) * 2006-08-17 2010-03-16 General Electric Company Locomotive wheel speed control

Similar Documents

Publication Publication Date Title
JP2006524342A5 (cg-RX-API-DMAC7.html)
DE60328885D1 (de) Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum
Duan et al. An ssDNA library immobilized SELEX technique for selection of an aptamer against ractopamine
JP2007534308A5 (cg-RX-API-DMAC7.html)
EP2177908A3 (en) Diabetes-associated markers and methods of use thereof
EE05465B1 (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
EP0837141A3 (en) Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
DE602005025998D1 (de) Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
JP2009533725A5 (cg-RX-API-DMAC7.html)
EP1550872A3 (en) Lateral flow quantitative assay method and strip, laser-induced epifluorescence detection device and small scanner therefor
WO2006119203A3 (en) Fluorescence lateral flow immunoassay
JP2009540314A5 (cg-RX-API-DMAC7.html)
DE10806564T1 (de) Nukleinsäureelement zur verwendung für analysen sowie analyseverfahren, analysereagens und analyseinstrument damit
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
Ongagna-Yhombi et al. Improved assay to detect Plasmodium falciparum using an uninterrupted, semi-nested PCR and quantitative lateral flow analysis
WO2008022150A3 (en) Method and apparatus for identifying and classifying query intent
DE502004005226D1 (de) Diagnosestellung von akuten myokardialen, ischämischen erkrankungen durch kombination von markern
BRPI0809958B8 (pt) conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
JP2007526998A5 (cg-RX-API-DMAC7.html)
ATE179799T1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
JP2017026631A5 (cg-RX-API-DMAC7.html)
ATE553386T1 (de) Bluttypisierung
Szpechcinski Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients
WO2006055816A3 (en) SOFTWARE INTEGRATED FLOW CYTOMETRIC ASSAY FOR QUANTIFICATION OF THE HUMAN POLYMORPHONUCLEAR LEUKOCYTE FcϜRI RECEPTOR (CD64)
Mandelker et al. Antigen expression patterns of MYC-rearranged versus non-MYC-rearranged B-cell lymphomas by flow cytometry